Merck Snags A Key Approval Before Its Cash Cow Goes Off A Patent Cliff - Investor's Business Daily

The Food and Drug Administration on Friday approved an injectable version of Merck's (MRK) biggest moneymaker, cancer behemoth Keytruda. But Merck stock shrugged off early gains and closed in the red…